BPC-157 5mg × 10 vials

A stable gastric pentadecapeptide studied for tissue repair research, tendon and ligament pathways, gastrointestinal integrity, angiogenesis-related mechanisms, inflammatory response, and broader recovery support protocols.

Product Overview

Compound: BPC-157
Strength: 5 mg per vial
Injection type: Research protocol dependent
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 5 mg
BAC water: 2 mL
Amount per unit: 25 mcg per unit

Research Dose

Protocol dependent.

Notes

BPC-157 is described as a stable gastric pentadecapeptide with the sequence GEPPPGKPADDAGLV. It has been studied in preclinical models for tissue repair, tendon and ligament research, gastrointestinal protection, wound-healing pathways, angiogenesis modulation, and inflammatory response mechanisms.

Most available evidence comes from animal and laboratory studies. Human efficacy data remain limited, so no standard consumer dosing protocol should be assumed.

Use only within appropriate research or professional guidance frameworks.

Disclaimer

This product is intended for research and informational purposes only.